Glycation and biomarkers of vascular complications of diabetes

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Amino Acids

• Publication date

  2010-11-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00726-010-0784-zPMID 21042818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic CKD/ESRD 2010: A Progress Report?

  2010cited by this paper
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• Early nephropathy in type 1 diabetes: the importance of early renal function decline

  2009cited by this paper
• Standards of medical care in diabetes--2007.

  2009cited by this paper
• RAGE: a novel biological and genetic marker for vascular disease.

  2009cited by this paper
• Susceptibility to Diabetic Nephropathy

  2009cited by this paper
• The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Renal and retinal effects of enalapril and losartan in type 1 diabetes.

  2009cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2008cited by this paper
• The Role of the Amadori Product in the Complications of Diabetes

  2008cited by this paper
• Glycemic targets and cardiovascular disease.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.

  2008cited by this paper
• Intensive glycemic control in the ACCORD and ADVANCE trials.

  2008cited by this paper
• Should the recommendation of the American Association of Clinical Endocrinologists for a hemoglobin A1c target of 6.5% be modified? A critical reappraisal of recent studies of intensive glycemic control.

  2008cited by this paper
• Biomarker discovery for kidney diseases by mass spectrometry.

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis.

  2007cited by this paper
• The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial

  2007cited by this paper
• Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy

  2007cited by this paper
• The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.

  2007cited by this paper
• Contributions of fasting and postprandial glucose to hemoglobin A1c.

  2006cited by this paper
• Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes

  2006cited by this paper
• Effects of statins beyond lipid lowering: potential for clinical benefits.

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

  2006cited by this paper
• Lipids and diabetic nephropathy

  2006cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.

  2005cited by this paper
• The Role of 3-Deoxyglucosone and the Activity of its Degradative Pathways in the Etiology of Diabetic Microvascular Disease

  2005cited by this paper
• Pericytes and the Pathogenesis of Diabetic Retinopathy

  2005cited by this paper
• Glycation Products as Markers and Predictors of the Progression of Diabetic Complications

  2005cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes

  2005influential reference
• Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

  2005cited by this paper
• Postprandial glucose regulation and diabetic complications.

  2004cited by this paper
• Molecular motors

  2003cited by this paper
• Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.

  2003cited by this paper
• Protein degradation and protection against misfolded or damaged proteins

  2003cited by this paper
• Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

  2003cited by this paper
• Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

  2003cited by this paper
• Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy.

  2003cited by this paper
• Pericytes and the pathogenesis of diabetic retinopathy.

  2002cited by this paper
• Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.

  2002cited by this paper
• Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

  2002cited by this paper
• Erratum: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes (Diabetes (2002) 51 (506-513)

  2002cited by this paper
• Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry.

  2002cited by this paper
• The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.

  2002cited by this paper
• ACE-I and ARBs in early diabetic nephropathy

  2002cited by this paper
• The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants.

  2002cited by this paper
• Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.

  2002cited by this paper
• Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

  2002cited by this paper
• Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes.

  2002cited by this paper
• Progression of diabetic nephropathy.

  2001cited by this paper
• Extracellular matrix remodeling: multiple paradigms in vascular disease.

  2001cited by this paper
• alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.

  2001cited by this paper
• Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus

  2001cited by this paper
• Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

  2000cited by this paper
• Glycoxidation and lipoxidation in atherogenesis.

  2000cited by this paper
• Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.

  2000cited by this paper
• Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group.

  1999cited by this paper
• THE CLINICAL SIGNIFICANCE OF GLYCATION

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs.

  1999cited by this paper
• Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

  1999cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• The Maillard reaction in foods and medicine

  1998cited by this paper
• Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?

  1998cited by this paper
• Chemical modification of proteins by methylglyoxal.

  1998cited by this paper
• Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)

  1998cited by this paper
• Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.

  1997cited by this paper
• Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial

  1997cited by this paper
• Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.

  1997cited by this paper
• Formation of N‐formylkynurenine suggests the involvement of apolipoprotein B‐100 centered tryptophan radicals in the initiation of LDL lipid peroxidation

  1996cited by this paper
• Diabetic retinopathy

  1995cited by this paper
• The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

  1995cited by this paper
• Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

  1993cited by this paper
• Accumulation of Maillard reaction products in skin collagen in diabetes and aging.

  1993cited by this paper
• Advanced glycosylation: chemistry, biology, and implications for diabetes and aging.

  1992cited by this paper
• Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a

  1992cited by this paper
• Glycation Products and the Pathogenesis of Diabetic Complications

  1992cited by this paper
• Is diabetic nephropathy an inherited complication?

  1992cited by this paper
• Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.

  1991cited by this paper
• Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus

  1990cited by this paper
• The maillard reaction in aging, diabetes and nutrition: edited by John W. Baynes and Vincent M. Monnier, Alan R. Liss, 1989. $85.00 (xvii + 432 pages) ISBN 0 8451 5154 1

  1990cited by this paper
• Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

  1989cited by this paper
• Toward a Maillard reaction theory of aging.

  1989cited by this paper
• Epidemiologic approach to the etiology of type I diabetes mellitus and its complications.

  1987cited by this paper
• Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

  1987cited by this paper
• Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

  1983cited by this paper
• Reaction of monosaccharides with proteins: possible evolutionary significance.

  1981cited by this paper
• Vitreous fluorophotometry: identification of sources of variability.

  1981cited by this paper

• LC-Orbitrap-MS/MS Analysis of Chosen Glycation Products in Infant Formulas

  2025cites this paper
• L-arginine overdose is a potential risk factor for myocardial injury in patients with type 2 diabetes

  2025cites this paper
• Decrypting the circular RNAs does a favor for us: Understanding, diagnosing and treating diabetes mellitus and its complications.

  2023cites this paper
• Extracellular vesicles regulate the transmission of insulin resistance and redefine noncommunicable diseases

  2023cites this paper
• Poor Glycemic Control Can Increase the Plasma Kidney Injury Molecule-1 Concentration in Normoalbuminuric Children and Adolescents with Diabetes Mellitus

  2021cites this paper
• Carbonyl Stress in Red Blood Cells and Hemoglobin

  2021cites this paper
• Effect of statin treatment in patients with acute myocardial infarction with prediabetes and type 2 diabetes mellitus

  2021cites this paper
• Erectile Dysfunction in Diabetic Patients: From Etiology to Management

  2021cites this paper
• Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance

  2020cites this paper
• Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study

  2020cites this paper
• Evaluation of metabolic changes in liver and serum of streptozotocin-induced diabetic rats after Mango diet supplementation

  2020cites this paper
• Glycated Whey Proteins Protect NOD Mice against Type 1 Diabetes by Increasing Anti-Inflammatory Responses and Decreasing Autoreactivity to Self-Antigens.

  2019cites this paper
• Lysulin and Testing HbA1c in the Pharmacy or at Home-How the Pharmacist can help their Customers with Diabetes to Better Health

  2019cites this paper
• Lysulin: Natural nutritional support to bring better health to people with diabetes and prediabetes

  2019cites this paper
• Methylglyoxal modification hinders amyloid conversion of prion protein

  2018cites this paper
• Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population

  2018cites this paper
• Studies in Antigen Presentation and Antigen Recognition at Different Interfaces of the Adaptive Immune System

  2018cites this paper
• Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein

  2016cites this paper
• Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology

  2016cites this paper
• High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus

  2016cites this paper
• Biomarkers for Diabetic Retinopathy – Could Endothelin 2 Be Part of the Answer?

  2016cites this paper
• Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

  2016cites this paper
• Elevated Levels of Urinary Markers of Oxidative DNA and RNA Damage in Type 2 Diabetes with Complications

  2015cites this paper
• Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study

  2015cites this paper
• Plants from ethnomedicines used against diabetes mellitus – rationale and quality control of Leonurus sibiricus L. (Lamiaceae) and Juglans regia L. (Juglandaceae)

  2015cites this paper
• Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation

  2014cites this paper
• Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications

  2014cites this paper
• Dyslipidemia and lipid peroxidation of Saudi type 2 diabetics with proliferative retinopathy.

  2013cites this paper
• Biogenesis of plasma CD36+microparticles in human diabetes and the metabolic syndrome

  2013cites this paper
• Associação dos fatores de risco cardiovasculares com os tipos de demência em diabéticos

  2013cites this paper
• Reactive Intermediates

  2013cites this paper
• Molecular signatures of oxidative stress: relevance to clinic and research

  2013cites this paper
• Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes.

  2013cites this paper
• Association Between Urinary Markers of Nucleic Acid Oxidation and Mortality in Type 2 Diabetes

  2013cites this paper
• Effect of the glucagon-like peptide-1 receptor agonist lixisenatide on postprandial hepatic glucose metabolism in the conscious dog.

  2013cites this paper
• The effect of physical activity counseling on diabetics' mobility : results of a secondary analysis

  2013cites this paper
• Circulating TGF-β1, Glycation, and Oxidation in Children with Diabetes Mellitus Type 1

  2012cites this paper
• DIABETIC RETINOPATHY AND ADIPONECTIN THROUGH 20 YEARS TYPE 1 DIABETES DURATION FOR THE WISCONSIN DIABETES REGISTRY STUDY

  2012cites this paper
• Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations.

  2012cites this paper
• [Skin autofluorescence measurement in the clinical practice of diabetology and nephrology].

  2012cites this paper
• Amino Acids Glycation Section

  2011cites this paper
• Utilização da espectroscopia de fluorescência para mensuramento de moléculas autoflurescentes em indivíduos diabéticos

  2011cites this paper
• The role of IL-18 in cross-susceptibility between periodontal disease and diabetes

  2011cites this paper
• Biomarkers for Diabetes Complications: The Results of Several Clinical Studies

  2011cites this paper
• World Journal of Diabetes

  year unknowncites this paper